Signup Crypto ETF Stocks News

AIP Realty Trust Announces Non-Brokered Offering of Preferred Units and Provides Update on AllTrades Transaction and Concurrent Financing

VANCOUVER, British Columbia, June 09, 2025 ( GLOBE NEWSWIRE ) -- AIP Realty Trust ( the "Trust" or "AIP" ) ( TSXV: AIP.U ) is pleased to announce a non-brokered private placement ( the "Financing" ) in which the Trust intends to issue up to 14,000,000 Preferred Units - Series B Convertible ( ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

Axsome Therapeutics Provides Update on the New Drug Application ( NDA ) for AXS-14 for the Management of Fibromyalgia

NEW YORK, June 09, 2025 ( GLOBE NEWSWIRE ) -- Axsome Therapeutics, Inc. ( NASDAQ: AXSM ) , a biopharmaceutical company leading a new era in the treatment of central nervous system ( CNS ) disorders, today announced it has received a Refusal to File ( RTF ) letter from the U.S.

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science

First consumer products roll out in Q3 2025, creating near-term revenue potential and marking a new chapter in Jupiter's evolution ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

REE Announces Cost Reduction Measures to Sustain Long-Term Growth

TEL AVIV, Israel, June 09, 2025 ( GLOBE NEWSWIRE ) -- REE Automotive Ltd. ( Nasdaq: REE ) , an automotive technology company that develops software-defined vehicle ( SDV ) technology solutions, today announced that it has implemented cost reductions across its business to streamline its cost ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

Vireo Growth Inc. Announces Closing of Deep Roots Harvest Acquisition in Nevada - Vireo Growth ( OTC:VREOF )

MINNEAPOLIS, June 09, 2025 ( GLOBE NEWSWIRE ) -- Vireo Growth Inc. ( "Vireo" or the "Company" ) VREOVREOF, today announced that it has closed its previously-announced transaction to acquire Nevada-based Deep Roots Holdings, Inc. ( "Deep Roots" ) .

Source: www.benzinga.com
June 09, 2025 | 11:00:00
Category: Mergers

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

NEW YORK, June 09, 2025 ( GLOBE NEWSWIRE ) -- IN8bio, Inc. ( Nasdaq: INAB ) , a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, announced that Patient 009 in the Phase 1 trial of INB-200 for newly-diagnosed GBM has ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial

- For the TransCon CNP treatment-naïve cohort, combination treatment resulted in mean annualized growth velocity ( AGV ) of 9.14 cm/year, with an improvement in mean ACH height Z-score of +0.53 over 26 weeks ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum

HOUSTON, June 09, 2025 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( OTC:BPTH ) , a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced Peter Nielsen, ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

Village Farms International Regains NASDAQ Compliance

VANCOUVER, British Columbia, June 09, 2025 ( GLOBE NEWSWIRE ) -- Village Farms International, Inc. ( "Village Farms" or the "Company" ) ( NASDAQ: VFF ) today announced that it received formal notice from The Nasdaq Stock Market LLC ( "Nasdaq" ) informing the Company that it has regained ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

NewAmsterdam Pharma Announces Positive Topline Alzheimer's Disease Data from BROADWAY Clinical Trial

-- Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer's disease biomarker in both the full ITT population ( p<0.002 ) and in ApoE4 carriers ( p=0.0215 ) , supporting the ...

Source: www.globenewswire.com
June 09, 2025 | 11:00:00
Category: News

© Natavest 2025 - 2026